ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AGEN Agenus Inc

16,97
0,00 (0,00%)
Pré-mercado
Última atualização: 06:14:43
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Agenus Inc AGEN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 16,97 06:14:43
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
16,97
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/05/202418:00BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
23/05/202418:10BWBreakthrough Data on Botensilimab/Balstilimab in MSS CRC..
23/05/202408:30BWAgenus to Participate in Goldman Sachs 45th Annual Global..
16/05/202408:30BWFDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss..
07/05/202408:40BWAgenus Reports First Quarter 2024 Results
01/05/202408:30BWAgenus Regains Compliance with Nasdaq Minimum Bid Price..
24/04/202411:00BWBotensilimab/Balstilimab Data in MSS CRC Selected for the..
23/04/202408:30BWAgenus to Provide First Quarter 2024 Financial Report and..
12/04/202408:30BWAgenus Announces Updated Phase 1 Data and Progress on..
05/04/202417:30BWAgenus Announces Reverse Stock Split of Common Stock
14/03/202408:30BWAgenus Reports Fourth Quarter and Full Year 2023 Results
06/03/202409:30BWAgenus Announces Preclinical Data on BMS-986442 (AGEN1777)..
05/03/202418:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
29/02/202409:30BWAgenus to Provide Corporate Update and Fourth Quarter & Full..
26/02/202409:30BWAgenus to Participate in Leerink Partners Global Biopharma..
15/02/202409:02PRNUSGinkgo Bioworks and SaponiQx Awarded MCDC Contract to..
31/01/202409:30BWAgenus to Participate in Oppenheimer 34th Annual Healthcare..
22/01/202411:59BWBotensilimab/Balstilimab Breakthrough Data Presented at..
22/01/202409:30BWBotensilimab/Balstilimab Breakthrough Data Presented at..
05/01/202418:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
04/01/202409:30BWAgenus to Participate in B. Riley Healthcare Conference
20/12/202309:30BWBotensilimab/Balstilimab Data in Neoadjuvant Colorectal..
11/12/202309:30BWAgenus to Receive $25 Million Milestone Payment from Bristol..
07/11/202308:30BWAgenus Reports Third Quarter 2023 Results
26/10/202310:05BWAgenus to Provide Third Quarter 2023 Financial Report and..
22/10/202313:00BWAgenus Unveils New and Updated Botensilimab Data in..
21/10/202305:15BWESMO 2023: Agenus’ Botensilimab/Balstilimab Combination..
10/10/202308:30BWAgenus Completes Enrollment in Randomized Phase 2 Clinical..
05/10/202308:30BWAgenus To Host BOT/BAL Program Update at ESMO 2023
01/09/202317:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
28/08/202308:30BWAgenus to Participate in September Investor Conferences
23/08/202309:00BWAgenus Prioritizes Resources to Accelerate Registration and..
09/08/202309:30BWSaponiQx Announces Breakthrough in Scaling Up of STIMULON™..
08/08/202308:30BWAgenus Reports Second Quarter 2023 Results
28/07/202308:30BWAgenus Botensilimab/Balstilimab Data Update in Sarcomas..
26/07/202308:30BWAgenus to Provide Second Quarter 2023 Financial Report and..
20/07/202308:30BWAgenus Expands Executive Leadership Team
30/06/202312:15BWESMO GI Data: Agenus' Botensilimab/Balstilimab Combination..
05/06/202310:49BWAgenus Presents Positive Efficacy and Safety Outcomes for..
05/06/202308:30BWAgenus Announces Virtual Annual Shareholders Meeting